Your browser doesn't support javascript.
loading
ProFertil study protocol for the investigation of gonadotropin-releasing hormone agonists (GnRHa) during chemotherapy aiming at fertility protection of young women and teenagers with cancer in Sweden-a phase III randomised double-blinded placebo-controlled study.
Rodriguez-Wallberg, Kenny A; Nilsson, Hanna Pauline; Bergh, Jonas; Malmros, Johan; Ljungman, Per; Foukakis, Theodoros; Stragliotto, Christina Linder; Friman, Erika Isaksson; Linderholm, Barbro; Valachis, Antonis; Andersson, Anne; Harrysson, Sara; Vennström, Lovisa; Frisk, Per; Mörse, Helena; Eloranta, Sandra.
Afiliación
  • Rodriguez-Wallberg KA; Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden kenny.rodriguez-wallberg@ki.se.
  • Nilsson HP; Department of Reproductive Medicine, Karolinska University Hospital, Stockholm, Sweden.
  • Bergh J; Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden.
  • Malmros J; Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden.
  • Ljungman P; Theme cancer, Karolinska Comprehensive Cancer Center and University Hospital, Stockholm, Sweden.
  • Foukakis T; Pediatric Theme Astrid Lindgren's Pediatric Hospital, Stockholm, Sweden.
  • Stragliotto CL; Department of Cellular Therapy and Allogeneic Stem Cell Transplantation, Karolinska University Hospital, Stockholm, Sweden.
  • Friman EI; Division of Hematology, Department of Medicine Huddinge, Karolinska Institute, Huddinge, Sweden.
  • Linderholm B; Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden.
  • Valachis A; Theme cancer, Karolinska Comprehensive Cancer Center and University Hospital, Stockholm, Sweden.
  • Andersson A; Theme cancer, Karolinska Comprehensive Cancer Center and University Hospital, Stockholm, Sweden.
  • Harrysson S; Department of Oncology, Capio ST, Göran Hospital, Stockholm, Sweden.
  • Vennström L; Department of Oncology, Sahlgrenska University Hospital, Goteborg, Sweden.
  • Frisk P; Oncology, Örebro universitet Fakulteten för medicin och hälsa, Orebro, Sweden.
  • Mörse H; Department of Oncology, Norrlands University Hospital, Umeå, Sweden.
  • Eloranta S; Department of Hematology, Cancer Theme, Karolinska University Hospital, Stockholm, Sweden.
BMJ Open ; 13(12): e078023, 2023 12 09.
Article en En | MEDLINE | ID: mdl-38070906
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Hormona Liberadora de Gonadotropina / Preservación de la Fertilidad / Linfoma Límite: Adolescent / Adult / Female / Humans País/Región como asunto: Europa Idioma: En Revista: BMJ Open Año: 2023 Tipo del documento: Article País de afiliación: Suecia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Hormona Liberadora de Gonadotropina / Preservación de la Fertilidad / Linfoma Límite: Adolescent / Adult / Female / Humans País/Región como asunto: Europa Idioma: En Revista: BMJ Open Año: 2023 Tipo del documento: Article País de afiliación: Suecia